Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Sidley says it advised Star51 Capital on UltraSight financing investment
Sidley Austin said it represented Star51 Capital in its investment in UltraSight’s $24 million Series B2 financing. The firm described UltraSight as a developer of AI-guided cardiac workflows and said the financing would support U.S. commercial expansion and further development of its platform.
Key points
- Sidley said Alive HealthTech Growth Fund led the round.Sidley Austin
- The firm identified Deep Insight, Connecticut Innovations and eHealth Ventures among the other participants.Sidley Austin
- Sidley said intended development areas include intensive care and circulatory support workflows.Sidley Austin
- The firm said Mayan Katz led its emerging companies and venture capital team.Sidley Austin